Log in
Enquire now
‌

US Patent 11446337 Bacteriotherapy for clostridium difficile colitis

Patent 11446337 was granted and assigned to Rebiotix on September, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Rebiotix
Rebiotix
0
Current Assignee
Rebiotix
Rebiotix
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114463370
Patent Inventor Names
Edwin J. Hlavka0
Date of Patent
September 20, 2022
0
Patent Application Number
159642280
Date Filed
April 27, 2018
0
Patent Citations
‌
US Patent 10434124 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10434125 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10434126 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10471107 Microbiota restoration therapy (MRT), compositions and methods of manufacture
0
‌
US Patent 10493111 Microbiota restoration therapy (MRT), compositions and methods of manufacture
0
‌
US Patent 10603341 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10610547 Microbiota restoration therapy (MRT), compositions and methods of manufacture
‌
US Patent 10624932 Microbiota restoration therapy (MRT), compositions and methods of manufacture
...
Patent Citations Received
‌
US Patent 12102655 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 11944654 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 11986500 Bacteriotherapy for clostridium difficile colitis
0
‌
US Patent 12083150 Microbiota restoration therapy (MRT), composition and methods of manufacture
0
Patent Primary Examiner
‌
David W Berke-Schlessel
0

This document discusses, among other things, receiving a plurality of donor fecal samples from a plurality of donors and storing and indexing each respective donor fecal samples using at least one characteristic of the respective donor fecal sample. In an example, the donor fecal sample can be screened and processed for subsequent use in fecal bacteriotherapy to displace pathogenic or undesired organisms in the digestive track of a patient with healthy or desirable gut microbiota.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11446337 Bacteriotherapy for clostridium difficile colitis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.